ALPMY OTC
Astellas Pharma Inc.
1W: -4.3%
1M: -5.3%
3M: +5.1%
YTD: +7.5%
1Y: +29.9%
3Y: +6.2%
5Y: -7.3%
$14.32
-0.12 (-0.83%)
Weekly Expected Move ±3.8%
$13
$14
$14
$15
$15
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$3.58T
+7.3% ▲
5Y CAGR: +9.5%
Total Liabilities
$1.74T
-4.5% ▼
5Y CAGR: +14.5%
Shareholders Equity
$1.84T
+21.5% ▲
5Y CAGR: +5.8%
Cash & Investments
$282.8B
+29.6% ▲
5Y CAGR: -2.8%
Total Debt
$247.0B
-70.3% ▼
5Y CAGR: -2.4%
Net Debt
-$35.8B
-105.6% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $316.0B | $376.8B | $335.7B | $188.4B | $282.8B |
| Short-Term Investments | $21.3B | $19.8B | $28.8B | $29.9B | $0 |
| Cash & ST Investments | $337.3B | $396.6B | $364.5B | $218.3B | $282.8B |
| Net Receivables | $382.5B | $428.0B | $535.0B | $632.5B | $765.1B |
| Inventory | $153.1B | $174.4B | $248.7B | $297.3B | $332.4B |
| Other Current Assets | $29.2B | $31.2B | $46.5B | $53.2B | $47.7B |
| Total Current Assets | $923.4B | $1.05T | $1.19T | $1.20T | $1.43T |
| Property, Plant & Equip. | $269.0B | $286.5B | $293.7B | $328.9B | $360.0B |
| Goodwill & Intangibles | $926.5B | $890.9B | $1.87T | $1.54T | $1.44T |
| Long-Term Investments | $131.7B | $134.7B | $144.4B | $172.2B | $159.3B |
| Other Non-Current Assets | $9.5B | $10.3B | $45.6B | $1M | $43.6B |
| Total Non-Current Assets | $1.41T | $1.41T | $2.37T | $2.14T | $2.15T |
| Total Assets | $2.33T | $2.46T | $3.57T | $3.34T | $3.58T |
| — Liabilities — | |||||
| Accounts Payable | $130.7B | $140.2B | $185.2B | $187.8B | $200.6B |
| Short-Term Debt | $157.7B | $75.0B | $472.3B | $266.5B | $247.0B |
| Deferred Revenue | $32.4B | $5.1B | $0 | $0 | $0 |
| Other Current Liabilities | $197.6B | $343.2B | $589.7B | $572.7B | $706.8B |
| Total Current Liabilities | $687.4B | $726.0B | $1.29T | $1.06T | $1.22T |
| Long-Term Debt | $0 | $50.0B | $447.7B | $564.9B | $0 |
| Other Non-Current Liab. | $129.0B | $106.9B | $188.8B | $194.4B | $518.7B |
| Total Non-Current Liabilities | $184.7B | $222.5B | $687.9B | $764.7B | $520.0B |
| Total Liabilities | $872.1B | $948.6B | $1.97T | $1.83T | $1.74T |
| — Equity — | |||||
| Common Stock | $103.0B | $103.0B | $103.0B | $103.0B | $103.4B |
| Retained Earnings | $944.3B | $908.2B | $809.4B | $740.9B | $906.8B |
| Accumulated OCI | $247.5B | $340.6B | $533.3B | $0 | $675.9B |
| Total Stockholders Equity | $1.46T | $1.51T | $1.60T | $1.51T | $1.84T |
| Total Liabilities & Equity | $2.33T | $2.46T | $3.57T | $3.34T | $3.58T |
| — Key Metrics — | |||||
| Total Debt | $212.7B | $200.0B | $920.0B | $831.4B | $247.0B |
| Net Debt | -$103.2B | -$176.8B | $584.3B | $643.1B | -$35.8B |
| Total Investments | $153.0B | $154.5B | $173.2B | $202.2B | $159.3B |